Valuation: China Resources Pharmaceutical Group Limited

Market Cap 30.47B 3.88B 3.36B 3.14B 2.87B 5.41B 370B 5.5B 36.85B 14.46B 185B 14.58B 14.26B 617B P/E 2026 *
6.14x
P/E 2027 * 5.75x
Enterprise Value 84.68B 10.79B 9.34B 8.73B 7.98B 15.04B 1,029B 15.28B 102B 40.19B 515B 40.53B 39.64B 1,715B EV / Sales 2026 *
0.26x
EV / Sales 2027 * 0.23x
Free-Float
29.17%
Yield 2026 *
4.28%
Yield 2027 * 4.67%
3 years 0.56
Extreme 0.56
0.56
5 years 0.56
Extreme 0.56
0.56
10 years 0.56
Extreme 0.56
0.56
Manager TitleAgeSince
President 47 2025-08-25
Director of Finance/CFO 54 2023-06-12
Corporate Secretary - 2025-12-14
Director TitleAgeSince
Director/Board Member 59 2016-05-31
Director/Board Member 70 2016-06-19
Chairman 55 2024-08-28
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 3.88B
+3.90%+9.86%+96.91%+136.30% 1,098B
+0.99%+2.91%+51.05%+52.06% 631B
+0.78%+1.17%+25.21%+63.74% 438B
+1.58%+4.80%+51.42%+39.79% 368B
+0.65%+1.85%+34.81%+39.99% 298B
+0.79%+4.26%+9.78%+7.42% 251B
+1.52%+10.12%+44.75%+59.20% 226B
+0.34%+1.27%-5.23%-50.94% 209B
-0.11%+1.46%+11.43%+66.32% 165B
Average +1.04%+3.10%+35.57%+45.99% 409.37B
Weighted average by Cap. +1.79%+4.82%+52.19%+68.54%

Financials

2026 *2027 *
Net sales 327B 41.68B 36.08B 33.73B 30.82B 58.08B 3,975B 58.99B 395B 155B 1,989B 157B 153B 6,623B 344B 43.82B 37.93B 35.46B 32.4B 61.06B 4,179B 62.02B 416B 163B 2,091B 165B 161B 6,963B
Net income 4.86B 620M 536M 501M 458M 863M 59.09B 877M 5.88B 2.31B 29.56B 2.33B 2.28B 98.45B 5.26B 670M 580M 542M 496M 934M 63.93B 949M 6.36B 2.5B 31.98B 2.52B 2.46B 107B
Net Debt 54.21B 6.91B 5.98B 5.59B 5.11B 9.63B 659B 9.78B 65.56B 25.73B 330B 25.95B 25.38B 1,098B 48.74B 6.21B 5.38B 5.03B 4.59B 8.66B 592B 8.79B 58.95B 23.13B 296B 23.33B 22.82B 987B
Logo China Resources Pharmaceutical Group Limited
China Resources Pharmaceutical Group Ltd is an investment holding company principally engaged in the pharmaceutical business. The Company operates its business through four segments. The Pharmaceutical Business segment develops, manufactures and sells a range of pharmaceuticals and health products. The Pharmaceutical Distribution Business segment provides distribution, warehousing, logistics and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers, device manufacturer and dispensers, including hospitals, distributors and retail pharmacies. The Pharmaceutical Retail Business segment operates retail pharmacies. The Other Business Operations segment engages in property holding and other businesses.
Employees
85,600
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
4.850HKD
Average target price
6.802HKD
Spread / Average Target
+40.25%

Quarterly revenue - Rate of surprise